IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $177,405 | -7.2% | 38,990 | +43.6% | 0.00% | 0.0% |
Q2 2023 | $191,206 | +112.0% | 27,160 | +84.0% | 0.00% | – |
Q1 2023 | $90,190 | -4.4% | 14,761 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $94,323 | -33.1% | 14,761 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $141,000 | -13.5% | 14,761 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $163,000 | -46.4% | 14,761 | -19.1% | 0.00% | 0.0% |
Q1 2022 | $304,000 | -17.8% | 18,247 | -6.0% | 0.00% | -50.0% |
Q4 2021 | $370,000 | +13.8% | 19,408 | +47.1% | 0.00% | 0.0% |
Q3 2021 | $325,000 | -5.2% | 13,191 | -0.0% | 0.00% | 0.0% |
Q2 2021 | $343,000 | -17.5% | 13,197 | +0.5% | 0.00% | 0.0% |
Q1 2021 | $416,000 | -35.4% | 13,136 | -5.4% | 0.00% | -50.0% |
Q4 2020 | $644,000 | +63.5% | 13,883 | +16.1% | 0.00% | +33.3% |
Q3 2020 | $394,000 | +30.9% | 11,959 | +9.1% | 0.00% | 0.0% |
Q2 2020 | $301,000 | +8.3% | 10,957 | +18.0% | 0.00% | 0.0% |
Q1 2020 | $278,000 | +26.4% | 9,285 | +16.7% | 0.00% | +50.0% |
Q4 2019 | $220,000 | +30.2% | 7,953 | -14.6% | 0.00% | +100.0% |
Q3 2019 | $169,000 | -25.9% | 9,313 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $228,000 | +88.4% | 9,313 | -26.8% | 0.00% | +100.0% |
Q1 2019 | $121,000 | +7.1% | 12,718 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $113,000 | -28.0% | 12,718 | -8.6% | 0.00% | 0.0% |
Q3 2018 | $157,000 | -11.8% | 13,918 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $178,000 | +22.8% | 13,918 | +61.8% | 0.00% | +100.0% |
Q1 2018 | $145,000 | – | 8,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |